Skip to main content
PMC home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1993 Oct;92(4):2048–2052. doi: 10.1172/JCI116800

Vasonatrin peptide: a unique synthetic natriuretic and vasorelaxing peptide.

C M Wei 1, C H Kim 1, V M Miller 1, J C Burnett Jr 1
PMCID: PMC288373  PMID: 8408658

Abstract

This study reports the cardiovascular and renal actions of a novel and newly synthesized 27-amino acid peptide termed vasonatrin peptide (VNP). VNP is a chimera of atrial natriuretic peptide (ANP) and C-type natriuretic peptide (CNP). This synthetic peptide possesses the 22-amino acid structure of CNP, which is a cardiovascular selective peptide of endothelial origin and is structurally related to ANP. VNP also possesses the five-amino acid COOH terminus of ANP. The current study demonstrates both in vitro and in vivo that VNP possesses the venodilating actions of CNP, the natriuretic actions of ANP, and unique arterial vasodilating actions not associated with either ANP or CNP.

Full text

PDF
2051

Images in this article

2049Image
on p.2049
2049Image
on p.2049

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bertinieri G., Cavallazzi A., Jaszlitz L., Ramirez A. J., Di Rienzo M., Mancia G. Differential control of blood pressure and heart rate by carotid and aortic baroreceptors in unanaesthetized cats. J Hypertens. 1987 Feb;5(1):51–56. doi: 10.1097/00004872-198702000-00008. [DOI] [PubMed] [Google Scholar]
  2. Brown J., Zuo Z. Renal receptors for atrial and C-type natriuretic peptides in the rat. Am J Physiol. 1992 Jul;263(1 Pt 2):F89–F96. doi: 10.1152/ajprenal.1992.263.1.F89. [DOI] [PubMed] [Google Scholar]
  3. Burnett J. C., Jr, Granger J. P., Opgenorth T. J. Effects of synthetic atrial natriuretic factor on renal function and renin release. Am J Physiol. 1984 Nov;247(5 Pt 2):F863–F866. doi: 10.1152/ajprenal.1984.247.5.F863. [DOI] [PubMed] [Google Scholar]
  4. Burnett J. C., Jr, Kao P. C., Hu D. C., Heser D. W., Heublein D., Granger J. P., Opgenorth T. J., Reeder G. S. Atrial natriuretic peptide elevation in congestive heart failure in the human. Science. 1986 Mar 7;231(4742):1145–1147. doi: 10.1126/science.2935937. [DOI] [PubMed] [Google Scholar]
  5. Clavell A. L., Stingo A. J., Wei C. M., Heublein D. M., Burnett J. C., Jr C-type natriuretic peptide: a selective cardiovascular peptide. Am J Physiol. 1993 Feb;264(2 Pt 2):R290–R295. doi: 10.1152/ajpregu.1993.264.2.R290. [DOI] [PubMed] [Google Scholar]
  6. Currie M. G., Geller D. M., Cole B. R., Siegel N. R., Fok K. F., Adams S. P., Eubanks S. R., Galluppi G. R., Needleman P. Purification and sequence analysis of bioactive atrial peptides (atriopeptins). Science. 1984 Jan 6;223(4631):67–69. doi: 10.1126/science.6419347. [DOI] [PubMed] [Google Scholar]
  7. Heublein D. M., Clavell A. L., Stingo A. J., Lerman A., Wold L., Burnett J. C., Jr C-type natriuretic peptide immunoreactivity in human breast vascular endothelial cells. Peptides. 1992 Sep-Oct;13(5):1017–1019. doi: 10.1016/0196-9781(92)90065-b. [DOI] [PubMed] [Google Scholar]
  8. Koller K. J., Lowe D. G., Bennett G. L., Minamino N., Kangawa K., Matsuo H., Goeddel D. V. Selective activation of the B natriuretic peptide receptor by C-type natriuretic peptide (CNP). Science. 1991 Apr 5;252(5002):120–123. doi: 10.1126/science.1672777. [DOI] [PubMed] [Google Scholar]
  9. Komatsu Y., Nakao K., Suga S., Ogawa Y., Mukoyama M., Arai H., Shirakami G., Hosoda K., Nakagawa O., Hama N. C-type natriuretic peptide (CNP) in rats and humans. Endocrinology. 1991 Aug;129(2):1104–1106. doi: 10.1210/endo-129-2-1104. [DOI] [PubMed] [Google Scholar]
  10. Schulz S., Singh S., Bellet R. A., Singh G., Tubb D. J., Chin H., Garbers D. L. The primary structure of a plasma membrane guanylate cyclase demonstrates diversity within this new receptor family. Cell. 1989 Sep 22;58(6):1155–1162. doi: 10.1016/0092-8674(89)90513-8. [DOI] [PubMed] [Google Scholar]
  11. Steiner A. L., Parker C. W., Kipnis D. M. Radioimmunoassay for cyclic nucleotides. I. Preparation of antibodies and iodinated cyclic nucleotides. J Biol Chem. 1972 Feb 25;247(4):1106–1113. [PubMed] [Google Scholar]
  12. Stingo A. J., Clavell A. L., Aarhus L. L., Burnett J. C., Jr Cardiovascular and renal actions of C-type natriuretic peptide. Am J Physiol. 1992 Jan;262(1 Pt 2):H308–H312. doi: 10.1152/ajpheart.1992.262.1.H308. [DOI] [PubMed] [Google Scholar]
  13. Stingo A. J., Clavell A. L., Heublein D. M., Wei C. M., Pittelkow M. R., Burnett J. C., Jr Presence of C-type natriuretic peptide in cultured human endothelial cells and plasma. Am J Physiol. 1992 Oct;263(4 Pt 2):H1318–H1321. doi: 10.1152/ajpheart.1992.263.4.H1318. [DOI] [PubMed] [Google Scholar]
  14. Suga S., Nakao K., Itoh H., Komatsu Y., Ogawa Y., Hama N., Imura H. Endothelial production of C-type natriuretic peptide and its marked augmentation by transforming growth factor-beta. Possible existence of "vascular natriuretic peptide system". J Clin Invest. 1992 Sep;90(3):1145–1149. doi: 10.1172/JCI115933. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Wei C. M., Aarhus L. L., Miller V. M., Burnett J. C., Jr Action of C-type natriuretic peptide in isolated canine arteries and veins. Am J Physiol. 1993 Jan;264(1 Pt 2):H71–H73. doi: 10.1152/ajpheart.1993.264.1.H71. [DOI] [PubMed] [Google Scholar]
  16. Wilcox J. N., Augustine A., Goeddel D. V., Lowe D. G. Differential regional expression of three natriuretic peptide receptor genes within primate tissues. Mol Cell Biol. 1991 Jul;11(7):3454–3462. doi: 10.1128/mcb.11.7.3454. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. de Bold A. J., Borenstein H. B., Veress A. T., Sonnenberg H. A rapid and potent natriuretic response to intravenous injection of atrial myocardial extract in rats. Life Sci. 1981 Jan 5;28(1):89–94. doi: 10.1016/0024-3205(81)90370-2. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES